Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study
In: Metabolism Open, Jg. 4 (2019-12-01), Heft -
Online
academicJournal
Zugriff:
Objectives: Galectin-1 is a recently discovered adipokine that increases with obesity and increased energy intake in adipose tissue. Our aim was to assess whether serum galectin-1 is associated with type 2 diabetes (T2D) and other parameters of the metabolic syndrome independently of body mass index (BMI) in a cohort from the general population. Methods: In this cross-sectional population-based cohort study from the western part of Sweden, we investigated associations between serum galectin-1, clinical characteristics and inflammatory markers in 989 women and men aged 50–65 years [part of the Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot cohort]. Results: We showed in linear models that serum galectin-1 was independently and: (1) inversely associated with T2D (p
Titel: |
Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study
|
---|---|
Autor/in / Beteiligte Person: | Fryk, Emanuel ; Strindberg, Lena ; Lundqvist, Annika ; Sandstedt, Mikael ; Bergfeldt, Lennart ; Lillemor Mattsson Hultén ; Bergström, Göran ; Jansson, Per-Anders |
Link: | |
Zeitschrift: | Metabolism Open, Jg. 4 (2019-12-01), Heft - |
Veröffentlichung: | Elsevier, 2019 |
Medientyp: | academicJournal |
ISSN: | 2589-9368 (print) |
DOI: | 10.1016/j.metop.2019.100017 |
Schlagwort: |
|
Sonstiges: |
|